FDA Approved: LEVETIRACETAM — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Levetiracetam (generic) submitted by Fresenius Kabi USA, LLC, under ANDA090876.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)